The latest news, updates and announcements from the Nuffield Department of Medicine.
16 November 2023
The Pandemic Sciences Institute has joined forces with the Science for Africa Foundation and the Mastercard Foundation to launch a call for applications to establish innovative networks of research excellence in epidemic and pandemic sciences across Africa.
9 November 2023
The AIDS Clinical Trials Group is starting a study to test a new HIV treatment. The study will enrol participants who initiated HIV treatment shortly after getting infected with HIV.
8 November 2023
The University of Oxford has announced a partnership with Danaher Corporation to develop a new test to enable precision medicine care for sepsis, a pathological immune response to infection that accounts for one in five deaths globally each year.
7 November 2023
The Global Health Network and the British Society for Antimicrobial Chemotherapy (BSAC) have signed a Memorandum of Understanding (MoU) establishing a framework for collaboration that can maximise the impact of shared antimicrobial resistance education, policy and advocacy efforts.
6 November 2023
Scientific advisors to the International Pandemic Preparedness Secretariat (IPPS) visited the University of Oxford’s vaccine laboratories as part of a two-day meeting of the global coalition.
3 November 2023
The Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Oxford announced the launch of a new project to initiate early development of prototype vaccines against the Junín virus. This is the first project to be initiated under CEPI and the University of Oxford’s strategic partnership to accelerate global pandemic preparedness efforts.
2 November 2023
The AELIX-002 study group research was awarded the European Hector Research Award in HIV for research on the therapeutic vaccine against HIV. The researchers include Prof Tomáš Hanke, Professor of Vaccine Immunology at the Jenner Institute at NDM.
1 November 2023
NDM’s Oxford University Clinical Research Unit in Viet Nam will be a part of a new initiative aimed at developing a strategic roadmap for Ho Chi Minh City to become a regional Health Innovation Hub. The project, supported by a £75,000 grant from the UK Government, is a strategic move to transform Ho Chi Minh City into ASEAN's leading health innovation centre.
30 October 2023
The Randomised Evaluation of COVid-19 thERapY (RECOVERY) trial, which discovered four effective treatments for COVID-19, has now expanded to investigate treatments for influenza (flu). The RECOVERY trial is a collaboration between the Nuffield Department of Medicine and the Nuffield Department of Population Health.
26 October 2023
The Broad One Health Endectocide-based Malaria Intervention in Africa project (BOHEMIA) begins its mass drug administration (MDA) activities in Kenya’s Kwale County. BOHEMIA is a consortium of multiple international organisations including the Centre for Tropical Medicine and Global Health at NDM.
20 October 2023
In collaboration with Ho Chi Minh City's healthcare sector, NDM's Oxford University Clinical Research Unit has successfully identified the primary agent causing the outbreak of pink eye disease. Testings revealed an unexpected finding: enterovirus was the primary agent, contrary to previous reports from Vietnam wherein adenovirus was the culprit.
10 October 2023
Today Oxford University has launched a new global collaboration backed by £8 million funding from UK Research and Innovation (UKRI). The project will be spearheaded by Professor Teresa Lambe, Professor of Vaccinology and Immunology and Calleva Head of Vaccine Immunology in the Department of Paediatrics and Professor Paul Klenerman, Sidney Truelove Professor of Gastroenterology and Director of the Translational Gastroenterology Unit at NDM, both of whom are Principal Investigators at NDM’s Pandemic Sciences Institute.
2 October 2023
The World Health Organization’s Strategic Advisory Group of Experts (SAGE) and Malaria Policy Advisory Group (MPAG) have recommended Oxford’s R21/Matrix-M™ malaria vaccine for use. The highly effective vaccine developed by the Jenner Institute and the Serum Institute of India has demonstrated high efficacy with a reassuring safety profile.
28 September 2023
A delegation from the Beijing Center for Disease Prevention and Control (Beijing CDC) visited the Chinese Academy of Medical Sciences Oxford Institute (COI) at NDM recently.
18 September 2023
A new clinical trial to find a vaccine to protect people against Middle East Respiratory Syndrome (MERS) launched on 15 September 2023. This is the third Phase I clinical trial of the ChAdOx1 MERS vaccine, developed by researchers at the Pandemic Sciences Institute. It is the first trial in older people.
15 September 2023
Researchers at the Pandemic Sciences Institute (PSI) are closely monitoring the current outbreak of deadly Nipah virus in Kerala, India. To date, there have been five confirmed cases and two deaths reported, with many of those affected being family members of the first patient. The Institute has collaborations with scientists involved in the response, including virologists at the National Institute of Virology in Pune.
11 September 2023
A University of Oxford study has administered a new vaccine against tick-borne virus Crimean-Congo haemorrhagic fever (CCHF) to volunteers for the first time. CCHF is on the World Health Organization's top priority watchlist for viruses that could cause a future pandemic, and yet no approved vaccines currently exist.
8 September 2023
We are delighted to announce that six researchers have been awarded the Professor title, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.
1 September 2023
One year on from the launch of the Ling Felce Award for the training of researchers in Oxford, we reflect on the impact of the award and the generosity of our donors.
30 August 2023
The Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Oxford have entered into a strategic partnership to accelerate the development of safe, effective and globally accessible vaccines to counter the threat of future pandemics.